REGENERON PHARMACEUTICALS, INC. Operating Cash Flow 2008-2025 | REGN
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is REGENERON PHARMACEUTICALS, INC.'s current operating cash flow?
REGENERON PHARMACEUTICALS, INC. (REGN) annual operating cash flow for 2025 was $4.98B, a 12.63% increase from 2024. REGENERON PHARMACEUTICALS, INC. operating cash flow for the quarter ending December 31, 2025 was $1.17B.
What was REGENERON PHARMACEUTICALS, INC.'s operating cash flow in 2024?
REGENERON PHARMACEUTICALS, INC. annual operating cash flow for 2024 was $4.42B, a 3.78% decline from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s operating cash flow in 2023?
REGENERON PHARMACEUTICALS, INC. annual operating cash flow for 2023 was $4.59B, a 8.39% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year operating cash flow CAGR?
REGENERON PHARMACEUTICALS, INC. operating cash flow grew at a compound annual growth rate (CAGR) of 13.72% from FY2020 to FY2025, going from $2.62B to $4.98B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.98B | +12.6% | 10-K |
| FY2024 | $4.42B | -3.8% | 10-K |
| FY2023 | $4.59B | -8.4% | 10-K |
| FY2022 | $5.01B | -29.2% | 10-K |
| FY2021 | $7.08B | +170.5% | 10-K |
| FY2020 | $2.62B | +7.7% | 10-K |
| FY2019 | $2.43B | +10.7% | 10-K |
| FY2018 | $2.20B | +67.9% | 10-K |
| FY2017 | $1.31B | -12.0% | 10-K |
| FY2016 | $1.49B | +11.7% | 10-K |
| FY2015 | $1.33B | +76.9% | 10-K |
| FY2014 | $752.4M | +27.8% | 10-K |
| FY2013 | $588.6M | +888.8% | 10-K |
| FY2012 | $-74.6M | +47.3% | 10-K |
| FY2011 | $-141.7M | -242.8% | 10-K |
| FY2010 | $99.2M | +241.9% | 10-K |
| FY2009 | $-69.9M | +21.5% | 10-K |
| FY2008 | $-89.1M | - | 10-K |